Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phase11 450 days CR% data for BTD approval in Dec 2022...

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Sep 05, 2022 9:41pm

287 Views

Post# 34942855

RE:RE:RE:RE:RE:RE:RE:RE:Phase11 450 days CR% data for BTD approval in Dec 2022...

I'm not sure why anything needs to be somber. The CR is moving up nicely. While some are discouraged that the 12 undertreated are weighing down the CR%, it strikes me that BTD doesn't have the same standard as a full APPROVAL. The FDA can look at the data and give BTD without risking accidentally approving something too early. Hopefully the full story of what has happened with the undertreated will factor in the decision.

I wonder if a company can contact your FDA liason and just say, "hey, should we submit this many with this CR and PR or should we wait for a few more patients?" You would think that the system would work best if there was some easy dialog about these things. IMO

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario